NeuCyte Licenses Its Novel Neuronal Programming Technology to Enable Academic Research

SUNNYVALE, Calif., Dec. 3, 2018 /PRNewswire/ -- NeuCyte, Inc., a leading neuroscience drug discovery company, announced that it has entered a license agreement with Boston Children's Hospital. As part of the agreement, Boston Children's has obtained a non-exclusive license from NeuCyte to manufacture transcription factor Ngn2 programmed induced neurons. The hospital intends to use this technology for internal research, teaching and educational purposes, and to perform services to other academic institutions.
"We are pleased to license this advantageous technology that was originated from Dr. Thomas Südhof's laboratory at Stanford University," said Mustafa Sahin, MD, PhD, director of the Translational Neuroscience Center and Human Neuron Core at Boston Children's and professor of neurology at Harvard Medical School. "We hope this technology will enable us and other researchers to create a tool that closely resembles human biology in vitro and will become an important part of our effort to improve human health."
"NeuCyte has the exclusive rights to Stanford's original neuronal induction technology and has further developed it to incorporate into our proprietary in vitro drug discovery platforms," said Jonathan Davila, PhD, Co-founder and CEO of NeuCyte. "We are happy to get the technology into the hands of Boston Children's Hospital where it can be further used for academic research. We also welcome discussions with other organizations who are interested in this technology."
About NeuCyte, Inc. NeuCyte is an innovative biotechnology company focused on developing impactful medicines for improving the lives of patients suffering from neurological disorders. Based on its proprietary SynFire® technology for generating human induced pluripotent stem cell (iPSC)-derived induced neural cells, NeuCyte has developed a highly functional in vitro platform for target identification and validation, efficacy testing, neurotoxicity assessment, and disease modeling. With the vast knowledge brought by its staff and scientific advisory board, NeuCyte is actively pursuing drug discovery programs for the treatment of Fragile X Syndrome, Epilepsy, ALS and more.
Contact: Ji Wu 1230 Bordeaux Drive Sunnyvale, CA 94089 ji.wu@neucyte.com



An NVQ in Administration is a work-based qualification designed to develop the practical knowledge and skills needed to perform effectively in administrative roles. It can cover areas such as office procedures, communication, document management, organisation, customer service, information handling, and supporting business operations. Advance your career with UNICCM and explore administration qualifications designed to help you gain industry-relevant skills and achieve long-term professional success.
hi
This article gives an interesting look at how technology influences modern art and changes our understanding of reality. I enjoyed reading about hyperreality and digital experiences. It is informative, creative, and thought-provoking. A tip.calculator is another useful everyday technology example.
Construction projects often require effective planning, communication, and the ability to manage multiple responsibilities simultaneously. Discussions relating to level 6 construction management frequently include project planning, team supervision, and the implementation of operational procedures within construction settings. These topics help illustrate how management principles support successful project delivery. Building awareness of industry practices remains valuable across many construction-related disciplines. Ongoing professional development continues to support long-term career growth.
One aspect that often gets overlooked in technology licensing is how much the success of a research collaboration depends on clearly defined responsibilities once the agreement is in place. Even when the scientific potential is strong, unclear milestones, intellectual property provisions, or publication rights can create unnecessary delays later. Developing a better understanding of these processes through a contract management course can be valuable for researchers and administrators involved in collaborative projects, especially as academic and commercial partnerships continue to become more common across emerging biomedical fields.